Association Mieux Prescrire
Acronym: AMP
General Information
Identification Code: 982539711698-79
Website: [object Object]
Entity Form: Non-profit continuing education organisation under the French law of 1901
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 8/8/2013
Last Update: 2/28/2024
EP Accredited Number: 0
Mission & Interests
Goals: Association Mieux Prescrire (AMP), is a non-for-profit continuing education organisation under the French law of 1901, and manages all of Prescrire's publications and programmes. The AMP bylaws contain this statement of purpose: "to work, in all independence, in favour of quality healthcare, first and foremost in the interest of patients (...).".
Nearly all of AMP's members are healthcare professionals, dedicated to providing quality medical and pharmaceutical information. AMP was set up in such a way as to ensure the ongoing independence, quality and usefulness of Prescrire's publications and programmes.
Interests Represented: Does not represent commercial interests
Interests:
- Business and industry
- Consumers
- Digital economy and society
- Environment
- Food safety
- Justice and fundamental rights
- Public health
- Research and innovation
- Single market
- Trans-European Networks
Levels of Interest:
- national
- global
- european
Activities
Main EU Legislative Proposals: Pharmaceutical Strategy
Revision of pharmaceuticals legislation
Clinical Trials
Advertising/Information to Patients
Pharmacovigilance
Measures affecting transparency of medicines prices
Adaptive Pathways/PRIME
Medical Devices
HTA
Paediatric Medicines
Orphan drugs
R&D
Transparency, access to documents and regulatory data
Clinical trials
Conflicts of interest
Compensation for victims of drug-induced harm
Communication Activities: Prescrire's publications (La revue Prescrire and Prescrire International) include articles linked to EU policies mentioned above, e.g. summaries of responses to public consultations; EMA transparency rules, etc.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Boulevard Voltaire, 83
Post Code: 75558
City: Paris Cedex 11
Country: FRANCE
Phone: [object Object]
EU Office
Address: Boulevard Voltaire, 83
Post Code: 75558
City: Paris Cedex 11
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 1
Structure
Structure Type: Structure
Is Member Of: Prescrire is participating in following networks:
International Society of Drug Bulletins (ISDB) (https://www.isdbweb.org)
International Medication Safety Network (https://www.intmedsafe.net)
Health Action International Europe (https://haiweb.org)
European Alliance for Responsible R&D and Affordable Medicines (www.medicinesalliance.eu)
Organisation Members: Prescrire collaborates with other independent bulletins and publications, organisations, and healthcare professionals around the world.
Other teams around the globe share the principles that Prescrire upholds: centred around access to quality information, independence from the pharmaceutical industry, having as ultimate goal better care for all patients.
Whenever possible, Prescrire works hand in hand with health professionals in other countries, participating in partnerships dedicated to the pursuit of these common goals.
Long-standing collaborations with the International Society of Drug Bulletins (ISDB) (https://www.isdbweb.org) , the International Medication Safety Network (https://www.intmedsafe.net) and Health Action International Europe (https://haiweb.org) all testify to Prescrire's commitment to international action and advocacy. Prescrire is also a member of the European Alliance for Responsible R&D and Affordable Medicines (www.medicinesalliance.eu)
Prescrire also helps to provide access to quality, independent information for professionals in emerging countries, via its Solidarity Support Programme.